RxDoctor Payments Data

Maria Baggstrom, MD

Medical Oncology · Saint Louis, MONPI 1679599971

Payments from drug & device makers

$26,649in general payments, 2019–2025

Across 2 payments — averaging $13,324 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$27K

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca2$26,649

How this compares

$26,649 in reported general payments places this provider in the 40th percentile of 144 medical oncology providers in Missouri.

See all medical oncology providers in Missouri

Medicare billing

Part B allowed, 2024
$872,199
Medicare patients
191
Services billed
37,535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MektoviBinimetinib12$127,950
EliquisApixaban18$14,802
XareltoRivaroxaban14$7,624
SavaysaEdoxaban Tosylate12$4,990
Prochlorperazine Maleate36$1,096
Ondansetron Hcl26$832
Oxycodone Hcl36$694
Triamcinolone Acetonide18$527
Dexamethasone47$463
Gabapentin32$252
Lidocaine-PrilocaineLidocaine/Prilocaine14$201
Pantoprazole Sodium25$139
Levothyroxine Sodium15$106
Naproxen12$81
Prednisone41$65

Paid to pharmacies, not to this prescriber.

Other medical oncology in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →